Role of Decorin in Posterior Capsule Opacification and Eye Lens Development.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
09 04 2021
Historique:
received: 25 02 2021
revised: 06 04 2021
accepted: 08 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 21 10 2021
Statut: epublish

Résumé

Decorin (DCN) is involved in a variety of physiological and pathological processes. Epithelial-mesenchymal transition (EMT) of lens epithelial cells (LECs) has been proposed as a major cause for the development of posterior capsule opacification (PCO) after cataract surgery. We investigated the plausible target gene(s) that suppress PCO. The expression of

Identifiants

pubmed: 33918979
pii: cells10040863
doi: 10.3390/cells10040863
pmc: PMC8070370
pii:
doi:

Substances chimiques

Decorin 0
Tpm1 protein, mouse 0
Transforming Growth Factor beta2 0
Tropomyosin 0
Fibroblast Growth Factors 62031-54-3

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NEI NIH HHS
ID : R01 EY024589
Pays : United States
Organisme : NEI NIH HHS
ID : EY024589
Pays : United States
Organisme : Japan Society for the Promotion of Science
ID : C 23592588

Références

J Biol Chem. 2008 Aug 1;283(31):21305-9
pubmed: 18463092
J Biol Chem. 2011 Jul 8;286(27):24242-52
pubmed: 21454550
Br J Ophthalmol. 2002 Dec;86(12):1428-33
pubmed: 12446380
Am J Pathol. 1997 Dec;151(6):1523-30
pubmed: 9403702
Growth Factors. 1989;1(2):125-34
pubmed: 2624777
Mol Vis. 2006 May 08;12:422-40
pubmed: 16710166
J Neurotrauma. 2006 Mar-Apr;23(3-4):397-408
pubmed: 16629625
Invest Ophthalmol Vis Sci. 1995 Jul;36(8):1701-8
pubmed: 7601650
Epigenetics. 2013 Mar;8(3):268-80
pubmed: 23386123
Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1930-9
pubmed: 15161860
Development. 1989 Oct;107(2):221-8
pubmed: 2632221
Histochem Cell Biol. 2003 Apr;119(4):289-99
pubmed: 12692670
Br J Ophthalmol. 1996 Jan;80(1):63-8
pubmed: 8664236
J Cell Mol Med. 2013 Jan;17(1):212-21
pubmed: 23205574
Ophthalmology. 1997 Dec;104(12):2168-74
pubmed: 9400780
Nature. 1992 Nov 26;360(6402):361-4
pubmed: 1280332
Am J Physiol Cell Physiol. 2008 Mar;294(3):C842-55
pubmed: 18184874
Development. 2001 Oct;128(20):3995-4010
pubmed: 11641223
Exp Eye Res. 2015 May;134:148-54
pubmed: 25704214
Graefes Arch Clin Exp Ophthalmol. 2011 Nov;249(11):1649-60
pubmed: 21735240
Cells Tissues Organs. 2005;179(1-2):43-55
pubmed: 15942192
Br J Ophthalmol. 2002 Feb;86(2):220-6
pubmed: 11815351
Ophthalmic Epidemiol. 2002 Apr;9(2):83-95
pubmed: 11821974
J Cataract Refract Surg. 2004 Dec;30(12):2598-605
pubmed: 15617931
J Cell Mol Med. 2013 Sep;17(9):1146-59
pubmed: 23844765
Oncogene. 2002 Jul 18;21(31):4765-77
pubmed: 12101415
Annu Rev Biochem. 1998;67:609-52
pubmed: 9759499
Microsurgery. 2008;28(2):113-6
pubmed: 18220313
Cell Death Differ. 2005 Jul;12(7):734-50
pubmed: 15818411
Exp Eye Res. 2002 Mar;74(3):337-47
pubmed: 12014915
Mol Biol Cell. 2017 Apr 1;28(7):907-921
pubmed: 28209733
Biochem J. 2001 Aug 15;358(Pt 1):41-8
pubmed: 11485550
J Cell Biol. 2009 May 18;185(4):743-54
pubmed: 19433454
Exp Cell Res. 2003 Jul 15;287(2):411-23
pubmed: 12837295
Graefes Arch Clin Exp Ophthalmol. 2015 Mar;253(3):409-17
pubmed: 25471020
Nat Med. 1996 Apr;2(4):418-23
pubmed: 8597951
Kidney Int. 2007 Apr;71(8):755-63
pubmed: 17290295
Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3743-57
pubmed: 26066743
Br J Ophthalmol. 2000 Mar;84(3):332-6
pubmed: 10684849
J Cell Mol Med. 2017 May;21(5):916-928
pubmed: 27976512
Mech Ageing Dev. 2006 Mar;127(3):249-56
pubmed: 16321424
Int J Mol Sci. 2018 Oct 09;19(10):
pubmed: 30304871
Graefes Arch Clin Exp Ophthalmol. 1998 Jul;236(7):531-6
pubmed: 9672800
J Biol Chem. 1998 Oct 23;273(43):28116-21
pubmed: 9774430
Eur J Neurosci. 2004 Mar;19(5):1226-42
pubmed: 15016081
Invest Ophthalmol Vis Sci. 2005 Jan;46(1):191-6
pubmed: 15623773
Invest Ophthalmol Vis Sci. 2000 Jun;41(7):1840-5
pubmed: 10845607
Sci Rep. 2018 Aug 24;8(1):12739
pubmed: 30143742
J Int Bioethique. 2004 Mar;15(1):124-9
pubmed: 15835069
J Biol Chem. 1998 Jan 2;273(1):271-8
pubmed: 9417075
Mech Ageing Dev. 2018 Apr;171:24-30
pubmed: 29510160

Auteurs

Shinsuke Shibata (S)

Department of Ophthalmology, Kanazawa Medical University, Ishikawa 9200293, Japan.

Naoko Shibata (N)

Department of Ophthalmology, Kanazawa Medical University, Ishikawa 9200293, Japan.

Satoshi Ohtsuka (S)

Medical Research Institute, Kanazawa Medical University, Ishikawa 9200293, Japan.
Laboratory for Experimental Animals, Kyoto Prefectural University of Medicine, Kyoto 6028566, Japan.

Yasuo Yoshitomi (Y)

Department of Biochemistry, Kanazawa Medical University, Ishikawa 9200293, Japan.

Etsuko Kiyokawa (E)

Department of Oncogenic Pathology, Kanazawa Medical University, Ishikawa 9200293, Japan.

Hideto Yonekura (H)

Department of Biochemistry, Kanazawa Medical University, Ishikawa 9200293, Japan.

Dhirendra P Singh (DP)

Department of Ophthalmology, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Hiroshi Sasaki (H)

Department of Ophthalmology, Kanazawa Medical University, Ishikawa 9200293, Japan.

Eri Kubo (E)

Department of Ophthalmology, Kanazawa Medical University, Ishikawa 9200293, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH